Clinical trial begins in NY for possible COVID-19 treatment

New York News

ALBANY, N.Y. (NEWS10) — A clinical trial, evaluating the effectiveness of a medication used to treat moderate to severe rheumatoid arthritis on the coronavirus, will begin at medical centers in New York.

Regeneron and Sanofi expect to have up to 400 patients, with severe symptoms, participating in the trial, Regeneron said on their investor page Monday.

“To initiate this trial quickly, so that the results may inform evidence-based treatment of this ongoing pandemic, Regeneron and Sanofi have worked closely with the U.S. Food and Drug Administration and the Biomedical Advanced Research and Development Authority, also known as the FDA and BARDA,” said Co-founder, President and Chief Scientific Officer of Regeneron, George D. Yancopoulos, M.D., Ph.D.

Yancopoulos said data from China indicated the drug may help curb the lung’s overactive inflammatory response to COVID-19. He also said Regeneron is working quickly to develop a vaccine and treatment specific to the virus.

Copyright 2021 Nexstar Media Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.

Latest Coronavirus Videos

Audience sits close at Trump's Mt Rushmore event

Expert: US leaving WHO would be 'gift' to China

Trump: FDA hydroxy warning based on 'phony study'

Kroger to give $130M in ‘Thank You’ pay

Fauci Testifies

Download our news app

App Store Link
Google Play Link
REMARKABLE WOMEN_2022_NOMINATE

Latest PODCAST episode

More PODCAST: On the Story with Trishna Begam
CHECK OUT OUR NEW APP FEATURES